These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9090476

  • 1. Taxanes in ovarian cancer treatment.
    Seetalarom K, Kudelka AP, Verschraegen CF, Kavanagh JJ.
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):14-20. PubMed ID: 9090476
    [Abstract] [Full Text] [Related]

  • 2. Docetaxel in the treatment of ovarian cancer.
    Kavanagh JJ.
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):73-81. PubMed ID: 12108900
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New options for the treatment of advanced ovarian cancer.
    Dunton CJ.
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [Abstract] [Full Text] [Related]

  • 12. Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Fossella FV.
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):4-8. PubMed ID: 10458203
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experience.
    Kudelka AP, Tresukosol D, Gonzalez de Leon C, Termrungruanglert W, Edwards CL, Freedman RS, Tornos C, Kavanagh JJ.
    J Med Assoc Thai; 1996 Apr; 79(4):240-5. PubMed ID: 8708510
    [Abstract] [Full Text] [Related]

  • 15. Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
    Mayerhofer K, Kucera E, Zeisler H, Speiser P, Reinthaller A, Sevelda P.
    Gynecol Oncol; 1997 Jan; 64(1):109-13. PubMed ID: 8995557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is there a place for "dose-dense" weekly schedules of the taxoids?
    Löffler TM.
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):32-4. PubMed ID: 9865710
    [Abstract] [Full Text] [Related]

  • 18. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD, Sledge GW.
    Cancer Invest; 1999 Oct; 17(2):121-36. PubMed ID: 10071597
    [Abstract] [Full Text] [Related]

  • 19. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
    Fossella FV, Lee JS, Berille J, Hong WK.
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.